Methyl 1-(3,4-dichlorobenzoyl)piperidine-4-carboxylate

Catalog No.: 
ACJBHL171
CAS No.: 
349616-92-8
Molecular Formula: 
C14H15Cl2NO3
Molecular Weight: 
316.18
Methyl 1-(3,4-dichlorobenzoyl)piperidine-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$140.00InquiryInquiry
100mg95%$198.00InquiryInquiry
250mg95%$275.00InquiryInquiry
1g95%$662.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 1-(3,4-dichlorobenzoyl)piperidine-4-carboxylate
IUPAC Namemethyl 1-(3,4-dichlorobenzoyl)piperidine-4-carboxylate
MDL No.MFCD02861994
Molecular FormulaC14H15Cl2NO3
Molecular Weight316.18
SMILESO=C(C1CCN(C(C2=CC=C(Cl)C(Cl)=C2)=O)CC1)OC
InChI KeyPJYQRGXTXWSQAU-UHFFFAOYSA-N
Synonymmethyl 1-(3,4-dichlorobenzoyl)piperidine-4-carboxylate;4-Piperidinecarboxylic acid, 1-(3,4-dichlorobenzoyl)-, methyl ester
CAS No.349616-92-8

Synthetic Route by SureRoute

1. ACJBHL171 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJBHL171 route product structure diagram
    ACJBHL171349616-92-8
Inquiry

2. ACJBHL171 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCGBP974 route compound structure diagram
    ACCGBP9747462-86-4
  2. Plus
  3. ACECAH195 route compound structure diagram
    ACECAH19551-44-5In Stock
  4. Then
  5. ACJBHL171 route product structure diagram
    ACJBHL171349616-92-8
Inquiry

3. ACJBHL171 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCGBP974 route compound structure diagram
    ACCGBP9747462-86-4
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJBHL171 route product structure diagram
    ACJBHL171349616-92-8
Inquiry

Comments (0)